C. Colby

发表

Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.

S. Saidman, F. Preffer, D. Dombkowski, 2003, Experimental hematology.

Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT

S. Saidman, D. Ting, A. Muzikansky, 2008, Bone Marrow Transplantation.

Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen

S. Saidman, D. Ting, N. Tarbell, 2007, Bone Marrow Transplantation.

Treatment of Chronic Hepatitis B Virus Infection Using a Mutant Recombinant Human β-Interferon

R. Guan, S. Leong, I. Yap, 1991 .

High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma – a phase II study

R. García-Carbonero, P. Multani, R. Sackstein, 2000, Bone Marrow Transplantation.

Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

S. Saidman, F. Preffer, D. Sachs, 1999, The Lancet.

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.

S. Saidman, F. Preffer, D. Sachs, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1

F. Delmonico, S. Saidman, D. Sachs, 2002, Transplantation.

Cryopreservation of microencapsulated canine islets.

G. Korbutt, J. Lakey, G. Warnock, 1995, Transplantation proceedings.

Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation

C. Colby, T. Spitzer, S. McAfee, 1998, Bone Marrow Transplantation.

Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.

G. Williams, C. Colby, 1989, Journal of interferon research.

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.

S. Saidman, N. Tarbell, D. Sachs, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.

S. Saidman, D. Sachs, M. Sykes, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation

R. Sackstein, C. Colby, T. Spitzer, 1999, Bone Marrow Transplantation.

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.

F. Delmonico, S. Saidman, D. Sachs, 1999, Transplantation.

Anti‐tumour response despite loss of donor chimaerism in patients treated with non‐myeloablative conditioning and allogeneic stem cell transplantation

S. Saidman, N. Tarbell, F. Preffer, 2005, British journal of haematology.

Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.

B. Storer, E. Borden, R. Brown, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

P. Hoeprich, P. Redlich, S. Grossberg, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.

B. Yeap, N. Tarbell, D. Sachs, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

J. Fishman, R. Sackstein, C. Colby, 1999, Bone Marrow Transplantation.

Antithymocyte Immunoglobulin in Severe Aplastic Anemia and Bone Marrow Transplantation

T. Spitzer, C. Stoukides, C. Colby, 1996, The Annals of pharmacotherapy.

Stable Multilineage Chimerism without Graft versus Host Disease Following Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation

D. Neville, T. Spitzer, A. Cameron, 2006, Transplantation.

Absence of Biological Effects of Orally Administered Interferon-βser

B. Storer, E. Borden, S. Grossberg, 1992 .

Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.

R. Schinazi, C. K. Chu, J. Sommadossi, 1990, Molecular pharmacology.

High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant

B. Yeap, C. Colby, T. Spitzer, 2002, Bone Marrow Transplantation.